Cargando…
Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy
Treatment and vaccine efficacy in clinical trials are often reported in the media and medical journals as the relative risk reduction. The present article explains why the relative risk reduction is a misinformative measure that promotes disinformation when reporting efficacy in clinical research st...
Autor principal: | Brown, Ronald B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647013/ https://www.ncbi.nlm.nih.gov/pubmed/36785641 http://dx.doi.org/10.1016/j.dialog.2022.100074 |
Ejemplares similares
-
Misinformation of COVID-19 vaccines and vaccine hesitancy
por: Lee, Sun Kyong, et al.
Publicado: (2022) -
Misinformation and COVID-19 vaccine hesitancy
por: Zimmerman, Tara, et al.
Publicado: (2023) -
Vaccine Hesitancy and Misinformation About Clinical Trials
por: Bhattacharya, Surajit
Publicado: (2021) -
Vaccine Hesitancy and Misinformation About Clinical Trials
por: Surajit, Bhattacharya
Publicado: (2021) -
Inoculating against COVID-19 vaccine misinformation
por: van der Linden, Sander, et al.
Publicado: (2021)